Fewer US men are diagnosed with low-risk prostate cancer, and more of them now choose surveillance over treatment

Fewer US men diagnosed with low-risk prostate cancer as surveillance replaces treatment

An analysis published in CANCER reveals a broad shift away from overtreatment of low-risk prostate cancer in the United States, with more men choosing surveillance over immediate treatment in response to concerns about overdiagnosis and overtreatment.